What Is DSIP?
Delta sleep-inducing peptide, commonly abbreviated as
DSIP, is a naturally occurring nonapeptide that has been
investigated for several decades in sleep and
neurobiological research.
Historical literature describes DSIP as a nine-amino-acid
peptide. Its reported sequence is
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, with a molecular mass
of approximately 849 daltons.
The original research program surrounding DSIP focused on
the possibility that endogenous peptide factors could
influence sleep. Subsequent studies investigated sleep
architecture, neuroendocrine measurements and several
additional experimental questions.
Compound
Delta sleep-inducing peptide
Abbreviation
DSIP
Peptide length
Nonapeptide
Why the Word "Dosage" Needs Context
A number appearing in a scientific paper is not
automatically a medically validated dose. Researchers
describe quantities within a particular experimental
framework that includes the species, study population,
route, formulation, timing, duration and research endpoint.
This distinction is especially important with DSIP because
much of the human literature is historical and involves
small exploratory studies. The best-known human studies
investigated sleep-related outcomes, while other work
examined endocrine or withdrawal-related questions.
Consequently, a historical research quantity should be
read as part of the description of that experiment rather
than converted into a recommendation for contemporary use.
Quantity
The amount of compound investigated in a particular
experiment.
Protocol
The complete experimental design surrounding that
quantity.
Clinical Dose
A validated medical dosing standard is a separate
question and cannot be inferred from one study.
What Human Studies Actually Investigated
The historical human literature provides the clearest
example of why research quantity and treatment
recommendation should remain separate.
Human Study
Healthy Volunteers
An early double-blind crossover study investigated
synthetic DSIP in six healthy volunteers. Researchers
evaluated sleep-related effects using extensive
psychophysiological observations.
The study reported an acute sleep-related effect after
experimental administration and also examined
subsequent nighttime sleep.
The very small sample size means that the study should
be regarded as an early exploratory experiment rather
than evidence establishing a general treatment standard.
Human Study
Chronic Insomnia
Another controlled study examined people with chronic
insomnia and used polysomnographic measurements to
evaluate sleep architecture and sleep quality.
The investigators reported some changes in sleep
measurements but concluded that the observed effects
were weak and that the short-term intervention was
unlikely to provide major therapeutic benefit.
Human Study
Repeated Sleep Research
A later placebo-controlled investigation studied
repeated experimental administration in middle-aged
people with chronic insomnia.
The publication reported improvements in several sleep
and daytime-performance measurements. However, this
historical result belongs to the specific experimental
population and design studied and does not establish
a modern clinical dosing standard.
Human Study
Endocrine Research
Human research also investigated whether DSIP could
influence neuroendocrine measurements. One randomized
crossover study measured ACTH-related and cortisol
responses after experimental administration.
The investigators reported a reduction in ACTH-like
immunoreactivity while cortisol followed its expected
pattern.
What the Human Literature Shows
The human DSIP literature is notable for being relatively
small, historically concentrated and methodologically
heterogeneous.
Small populations
Several early investigations involved only a small
number of participants.
Historical evidence
Much of the best-known human work was published
decades ago.
Mixed findings
Different studies did not produce a uniformly strong
pattern across every sleep measurement.
No established standard
Historical quantities should not be mistaken for a
universally validated clinical regimen.
Historical Research Parameters
Published papers describe the quantities used within their
own experimental designs. The table below deliberately
summarizes the research context rather
than turning those historical parameters into a dosing
chart.
|
Research Area
|
Population / Model
|
What Was Investigated
|
Evidence Context
|
|
Sleep research
|
Healthy human volunteers
|
Acute and subsequent sleep-related effects
|
Very small early crossover study
|
|
Insomnia research
|
Adults with chronic insomnia
|
Sleep architecture, latency, efficiency and
subjective measures
|
Controlled historical clinical research
|
|
Repeated sleep research
|
Middle-aged adults with chronic insomnia
|
Night sleep and daytime performance
|
Placebo-controlled historical investigation
|
|
Endocrine research
|
Healthy adult volunteers
|
ACTH-related and cortisol measurements
|
Randomized crossover research
|
|
Preclinical research
|
Various animal models
|
Sleep, neurobiology and other experimental endpoints
|
Animal findings cannot be converted directly into
human dosing
|
Human Research vs Animal Research
DSIP literature spans both human and animal experiments.
These two evidence categories should be kept separate when
reading a research summary.
Human Evidence
Human Studies
Human research can provide information about observed
responses in people under the specific conditions of
the study.
The historical DSIP human studies were generally small
and focused on particular experimental questions,
particularly sleep and neuroendocrine measurements.
Preclinical Evidence
Animal Studies
Animal research can be useful for exploring biological
mechanisms, experimental endpoints and hypotheses that
may later warrant additional investigation.
An animal quantity is not a human dose. Differences in
metabolism, physiology, body size, exposure and route
make direct conversion inappropriate.
Why Online DSIP Dosing Charts Can Be Misleading
Online peptide discussions frequently combine numbers from
unrelated studies, unpublished protocols, animal experiments
and commercial product instructions. This can make a
numerical value appear much more established than the
underlying evidence actually supports.
The Unit Matters
A quantity expressed in nanomoles is not interchangeable
with the same numerical quantity expressed in micrograms.
The molecular weight of the compound determines the
relationship between those units.
The Route Matters
Results from one administration route cannot automatically
establish an equivalent exposure through another route.
Absorption and bioavailability can differ substantially.
The Model Matters
A quantity used in a laboratory animal experiment answers
a different scientific question from a quantity studied
in a human clinical investigation.
The Endpoint Matters
A change in a sleep measurement, hormone marker or other
experimental endpoint does not automatically establish a
clinical benefit.
Research-reading rule:
Never copy a number from a secondary website without first
checking the original publication, species or population,
units, route, study design and measured endpoint.
What These Studies Did Not Establish
Historical research can be scientifically interesting
without establishing a modern treatment protocol. The
published DSIP literature does not justify treating an
isolated historical quantity as a universal recommendation.
No Universal Dose
A study-specific research quantity is not automatically
a universally validated dose.
No Automatic Conversion
Animal quantities or one administration route cannot
simply be converted into another human protocol.
No Proof of General Benefit
Individual experimental findings do not establish
effectiveness for every person or condition.
How to Read a DSIP Study Properly
01
Identify the Population
Determine whether the study involved healthy
volunteers, people with a particular condition,
or an animal model.
02
Identify the Experimental Quantity
Check the exact units reported by the original
publication rather than relying on a secondary
summary.
03
Identify the Experimental Route
Determine how the compound was delivered within the
study and avoid assuming equivalence with another
route.
04
Examine the Endpoint
Ask exactly what the investigators measured and
whether the reported result was statistically and
clinically meaningful.
05
Read the Authors' Conclusion
Compare the paper's actual conclusion with claims
made by secondary websites or commercial material.
Limitations of the DSIP Literature
-
Many important human investigations are several decades old.
-
Some studies involved very small participant groups.
-
Experimental designs and endpoints varied between studies.
-
Historical findings have not established a single
universally accepted clinical protocol.
-
Animal findings cannot be assumed to predict human
responses.
-
A reported biological effect is not automatically evidence
of a clinically meaningful benefit.
-
Secondary websites may omit important information such as
units, population, route or study limitations.
Research Quantity Is Not the Same as Material Quality
A scientific paper describes the material and experimental
conditions used in that particular investigation. It does
not automatically establish the identity, purity or
analytical quality of a commercially supplied research
material.
When evaluating a research peptide, laboratory personnel
should review the applicable product documentation and
certificate of analysis for the specific material or batch.
Identity
Confirm that the analytical documentation identifies
the intended peptide.
Batch Traceability
Documentation should correspond to the specific lot
or batch being evaluated.
Purity Method
Review the analytical method and specification rather
than relying only on a percentage.
Supporting Documentation
Review relevant analytical and safety documentation
supplied for the material.
DSIP Research Summary
DSIP has a long research history, particularly in the field
of sleep-related investigation. Early human studies examined
experimental effects on sleep, while later work investigated
additional physiological measurements.
The human literature includes both favorable findings and
studies reporting weak or limited effects. For example, one
controlled insomnia study reported some objective sleep
changes but concluded that the effects were weak and not
likely to represent major therapeutic benefit.
Other historical work reported sleep-related effects in
small volunteer groups, while an endocrine study examined
changes in ACTH-related measurements.
Bottom line:
The scientifically useful question is not simply
"What dose of DSIP should be used?" The more defensible
research question is "What quantities, populations, routes,
endpoints and study designs have actually been investigated,
and what did those studies conclude?"
Frequently Asked Questions
Is there an established standard DSIP dose?
The historical literature contains study-specific
quantities, but those publications should not be
interpreted as establishing a universal modern clinical
dosing standard.
Why do different websites give different DSIP numbers?
Secondary sources can combine human studies, animal
studies, different units, different routes and
unverified online protocols. A number is meaningful only
when its original study context is identified.
Does an animal DSIP study establish a human dose?
No. Animal research and human research are different
evidence categories. Animal quantities should not be
converted directly into human dosing instructions.
Were humans studied with DSIP?
Yes. Historical human investigations examined sleep,
insomnia and neuroendocrine measurements. These studies
were generally small and should be interpreted in their
original experimental context.
Were the human studies all positive?
No. Results were not uniformly strong. Some studies
reported improvements in particular sleep measurements,
while other controlled work characterized the effects
as weak or of limited clinical significance.
Why is the exact unit important when reading DSIP research?
Different units represent different quantities.
Nanomoles and micrograms are not numerically
interchangeable. Researchers should always consult the
original publication before interpreting a reported
quantity.
Does this page provide a DSIP dosing protocol?
No. This page is a literature review describing what
studies investigated. It does not provide a personal
dosing schedule, administration instructions,
reconstitution procedure or treatment protocol.
Can published DSIP research prove that a product is safe?
No. Published research on a compound and analytical
documentation for a particular commercial batch answer
different questions. Material identity, purity,
documentation and applicable safety information should
be evaluated separately.
Selected Research Sources
The following publications provide useful starting points
for reviewing the historical human DSIP literature.
-
Schneider-Helmert et al. (1981)
— Acute and delayed effects of DSIP on human sleep
behavior. PubMed PMID 6895513.
-
Schneider-Helmert & Schoenenberger (1981)
— Influence of synthetic DSIP on disturbed human sleep.
PubMed PMID 7028502.
-
Schneider-Helmert (1984)
— DSIP in insomnia. European Neurology.
PubMed PMID 6391925.
-
Monti et al. (1987)
— Study of DSIP efficacy in improving sleep on short-term
administration to chronic insomniacs.
PubMed PMID 3583493.
-
Schneider-Helmert (1987)
— Effects of DSIP on 24-hour sleep-wake behaviour in
severe chronic insomnia. PubMed PMID 3622582.
-
Bes et al.
— Effects of DSIP on sleep of chronic insomniac patients.
PubMed PMID 1299794.
-
Human endocrine research
— Study examining ACTH-related and cortisol responses
following experimental DSIP administration.
PubMed PMID 2554357.
Research Use & Regulatory Notice
The information on this page is provided for educational
and research-literature purposes. It is not medical advice,
a treatment recommendation, a prescription, or a substitute
for advice from a qualified healthcare professional.
The presence of historical human research does not by itself
establish current regulatory approval, clinical efficacy,
product quality or suitability for a particular purpose.
Regulatory status can vary by jurisdiction and can change
over time.
Researchers and institutions should follow applicable
institutional, laboratory, ethical, safety and regulatory
requirements when working with research compounds.
Important:
Nothing on this page should be interpreted as an instruction
to administer DSIP to a person or animal.
